Par Pharmaceuticals Competitors, Revenue, Alternatives and Pricing

Claim your profile

Overview

Location:
Spring Valley, NY USA
Total Funding:N/A
Industry:Pharma
Founded:1978
Lead Investor(s):N/A

Estimated Revenue & Financials

  • Par Pharmaceuticals's estimated annual revenue is currently $372.5M per year.
  • Par Pharmaceuticals's estimated revenue per employee is $201,000

Employee Data

  • Par Pharmaceuticals has 1853 Employees.
  • Par Pharmaceuticals currently has 1 job openings.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingOnline ReviewPricing
#1
N/A686N/AN/A-N/A
#2
$372.5M1853N/AN/A-N/A
#3
$38.2M190N/AN/A-N/A
#4
N/A36N/AN/A-N/A
#5
$22.1M11024%N/A-N/A
#6
$581.3M2892N/AN/A-N/A
#7
$13.5M67N/AN/A-N/A
#8
$43.4M216N/AN/A-N/A
#9
$15.1M7510%N/A-N/A
#10
$47.4M23615%N/A4.2/5N/A
Missing a competitor? Contribute!?
Submit

Pharmaceutical Resources, Inc. (PRI) is a holding company that, through its subsidiaries, is in the business of developing, manufacturing and distributing a broad line of generic drugs in the United States. PRI operates primarily through its wholly owned subsidiary, Par Pharmaceutical, Inc., a manufacturer and distributor of generic drugs. The Company's product line consists of prescription and, to a lesser extent, over-the-counter generic drugs consisting of approximately 119 products representing various dosage strengths for 51 drugs. In addition to manufacturing its own products, the Company has strategic alliances with several pharmaceutical and chemical companies providing it with products for sale through distribution, development or licensing agreements. The Company markets its products primarily to wholesalers, retail drug store chains, drug distributors and repackagers.

keywords:N/A

1853

Number of Employees

$372.5M

Revenue (est)

1

Current Jobs

N/A

Employee Growth %

N/A

Total Funding

N/A

Valuation

N/A

Accelerator

N/A

Type

Company NameRevenueNumber of EmployeesEmployee GrowthTotal FundingOnline ReviewPricing
#1
N/A3175N/AN/A-N/A
#2
N/A4492N/AN/A-N/A